BioXcel Therapeutics (BTAI) Gross Profit (2022 - 2026)
BioXcel Therapeutics' (BTAI) quarterly Gross Profit came in at -$77000.0 in Q1 2026, down 150.0% year-on-year from $154000.0 in Q1 2025, and down 134.38% quarter-over-quarter from $224000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Gross Profit (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Gross Profit history runs 5 years deep, the most recent figure standing at -$77000.0 for Q1 2026.
- On a quarterly basis, Gross Profit fell 150.0% year-over-year to -$77000.0 in Q1 2026; TTM through Mar 2026 was $247000.0, a 209.29% increase from a year earlier, with the FY2025 full-year figure at $478000.0, up 288.62% from the prior year.
- Gross Profit fell to -$77000.0 in Q1 2026 per BTAI's latest filing, from $224000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $1.0 million in Q2 2024 and bottomed at -$956000.0 in Q3 2024.
- The 5-year median for Gross Profit is $126000.0 (2022), against an average of $66466.7.
- Biggest YoY gain for Gross Profit was 154.82% in 2024; the steepest drop was 459.06% in 2024.
- Year by year, Gross Profit stood at $229000.0 in 2022, then slumped by 247.6% to -$338000.0 in 2023, then plunged by 37.87% to -$466000.0 in 2024, then jumped by 148.07% to $224000.0 in 2025, then plunged by 134.38% to -$77000.0 in 2026.
- Per Business Quant, the three latest BTAI Gross Profit figures stand at -$77000.0 (Q1 2026), $224000.0 (Q4 2025), and $87000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | BioXcel Therapeutics | 10.62 Mn | 10.62 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | -466,000.00 |
| Dec 31, 2024 | -466,000.00 |
| Sep 30, 2024 | -956,000.00 |
| Sep 30, 2024 | -956,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 502,000.00 |
| Mar 31, 2024 | 502,000.00 |
| Dec 31, 2023 | -338,000.00 |
| Dec 31, 2023 | -338,000.00 |